These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15359573)

  • 21. In-vitro and in-vivo transdermal iontophoretic delivery of tramadol, a centrally acting analgesic.
    Takasuga S; Yamamoto R; Mafune S; Sutoh C; Kominami K; Yoshida Y; Ito M; Kinoshita M
    J Pharm Pharmacol; 2011 Nov; 63(11):1437-45. PubMed ID: 21988424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro permeability of a model protein across ocular tissues and effect of iontophoresis on the transscleral delivery.
    Tratta E; Pescina S; Padula C; Santi P; Nicoli S
    Eur J Pharm Biopharm; 2014 Sep; 88(1):116-22. PubMed ID: 24816128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Model describing transdermal iontophoretic delivery of lidocaine incorporating consideration of cutaneous microvascular state.
    Williams PL; Riviere JE
    J Pharm Sci; 1993 Nov; 82(11):1080-4. PubMed ID: 8289117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous iontophoretic delivery of CGP69669A, a sialyl Lewis(x) mimetic, in vitro.
    Gratieri T; Wagner B; Kalaria D; Ernst B; Kalia YN
    Exp Dermatol; 2012 Mar; 21(3):226-8. PubMed ID: 22379971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.
    Cázares-Delgadillo J; Naik A; Ganem-Rondero A; Quintanar-Guerrero D; Kalia YN
    Pharm Res; 2007 Jul; 24(7):1360-8. PubMed ID: 17457661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transdermal delivery and the premature neonate.
    Barrett DA; Rutter N
    Crit Rev Ther Drug Carrier Syst; 1994; 11(1):1-30. PubMed ID: 7704917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl.
    Silva SM; Hu L; Sousa JJ; Pais AA; Michniak-Kohn BB
    Eur J Pharm Biopharm; 2012 Apr; 80(3):663-73. PubMed ID: 22137964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo: Transdermal polypharmacy to treat Parkinson's disease.
    Kalaria DR; Singhal M; Patravale V; Merino V; Kalia YN
    Eur J Pharm Biopharm; 2018 Jun; 127():204-212. PubMed ID: 29477356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transdermal iontophoretic delivery of tacrine hydrochloride: Correlation between in vitro permeation and in vivo performance in rats.
    Patel N; Jain S; Lin S
    Int J Pharm; 2016 Nov; 513(1-2):393-403. PubMed ID: 27633278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal iontophoretic delivery of triptorelin in vitro.
    Schuetz YB; Naik A; Guy RH; Vuaridel E; Kalia YN
    J Pharm Sci; 2005 Oct; 94(10):2175-82. PubMed ID: 16136544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced transdermal delivery of low molecular weight heparin by barrier perturbation.
    Lanke SS; Kolli CS; Strom JG; Banga AK
    Int J Pharm; 2009 Jan; 365(1-2):26-33. PubMed ID: 18801420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of controlled laser microporation on drug transport kinetics into and across the skin.
    Bachhav YG; Summer S; Heinrich A; Bragagna T; Böhler C; Kalia YN
    J Control Release; 2010 Aug; 146(1):31-6. PubMed ID: 20678988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal iontophoresis and solute penetration across excised human skin.
    Singh P; Anliker M; Smith GA; Zavortink D; Maibach HI
    J Pharm Sci; 1995 Nov; 84(11):1342-6. PubMed ID: 8587053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo.
    Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN
    Eur J Pharm Biopharm; 2014 Sep; 88(1):56-63. PubMed ID: 24525072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transdermal and transbuccal drug delivery systems: enhancement using iontophoretic and chemical approaches.
    Hu L; Silva SM; Damaj BB; Martin R; Michniak-Kohn BB
    Int J Pharm; 2011 Dec; 421(1):53-62. PubMed ID: 21963468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal iontophoretic delivery of a liquid lipophilic drug by complexation with an anionic cyclodextrin.
    Juluri A; Narasimha Murthy S
    J Control Release; 2014 Sep; 189():11-8. PubMed ID: 24950431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transdermal permeation of drugs with differing lipophilicity: Effect of penetration enhancer camphor.
    Xie F; Chai JK; Hu Q; Yu YH; Ma L; Liu LY; Zhang XL; Li BL; Zhang DH
    Int J Pharm; 2016 Jun; 507(1-2):90-101. PubMed ID: 27154251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro study of transdermal penetration and iontophoresis of hepatitis B vaccines through rat skin.
    Xu T; Xu YH; Wei MY; Deng LH; Wu CB
    Yao Xue Xue Bao; 2011 Jun; 46(6):713-9. PubMed ID: 21882534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biophysical study of porcine ear skin in vitro and its comparison to human skin in vivo.
    Sekkat N; Kalia YN; Guy RH
    J Pharm Sci; 2002 Nov; 91(11):2376-81. PubMed ID: 12379922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.